QUILLIVANT Trademark

Trademark Overview

On Friday, May 27, 2011, a trademark application was filed for QUILLIVANT with the United States Patent and Trademark Office. The USPTO has given the QUILLIVANT trademark a serial number of 85332659. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, April 20, 2023. This trademark is owned by NextWave Pharmaceuticals, Inc.. The QUILLIVANT trademark is filed in the Pharmaceutical Products category with the following description:

Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder
quillivant

General Information

Serial Number85332659
Word MarkQUILLIVANT
Filing DateFriday, May 27, 2011
Status800 - REGISTERED AND RENEWED
Status DateThursday, April 20, 2023
Registration Number4392798
Registration DateTuesday, August 27, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2011

Trademark Statements

Goods and ServicesOral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder
Translation of Words in MarkThe wording "QUILLIVANT" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 2, 2011
Primary Code005
First Use Anywhere DateMonday, January 14, 2013
First Use In Commerce DateMonday, January 14, 2013

Trademark Owner History

Party NameNextWave Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
Party NameNextWave Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCupertino, CA 95014
Party NameNextWave Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCupertino, CA 95014

Trademark Events

Event DateEvent Description
Thursday, April 20, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, April 20, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, April 20, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 20, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, October 7, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, August 27, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, August 26, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, August 26, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 26, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 16, 2019TEAS SECTION 8 & 15 RECEIVED
Tuesday, February 5, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 5, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 3, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, August 27, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 27, 2013REGISTERED-PRINCIPAL REGISTER
Thursday, July 25, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, July 24, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, July 19, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 18, 2013STATEMENT OF USE PROCESSING COMPLETE
Monday, June 24, 2013USE AMENDMENT FILED
Thursday, July 18, 2013SOU EXTENSION 3 GRANTED
Friday, June 21, 2013SOU EXTENSION 3 FILED
Friday, July 12, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 24, 2013TEAS STATEMENT OF USE RECEIVED
Friday, June 21, 2013TEAS EXTENSION RECEIVED
Friday, January 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 17, 2013SOU EXTENSION 2 GRANTED
Thursday, December 20, 2012SOU EXTENSION 2 FILED
Thursday, December 20, 2012TEAS EXTENSION RECEIVED
Thursday, December 13, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 13, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 20, 2012SOU EXTENSION 1 GRANTED
Tuesday, June 26, 2012SOU EXTENSION 1 FILED
Friday, July 20, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 26, 2012TEAS EXTENSION RECEIVED
Tuesday, December 27, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 1, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2011PUBLISHED FOR OPPOSITION
Wednesday, September 28, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 27, 2011ASSIGNED TO LIE
Thursday, September 15, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 15, 2011EXAMINER'S AMENDMENT ENTERED
Thursday, September 15, 2011NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 15, 2011EXAMINERS AMENDMENT E-MAILED
Thursday, September 15, 2011EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 14, 2011ASSIGNED TO EXAMINER
Thursday, June 2, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 31, 2011NEW APPLICATION ENTERED

Related Keywords

quillivant treatment disorders diseases attention deficit disorder hyperactivity oral system suspension